Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VANI
VANI | US
1.17
USD0
0%
VANI | US
About VANI
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
1.17
Open
1.15
High
1.19
Low
1.15
Vivani Medical Inc. a clinical stage company develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville California.
View LessVANI | US
Risk
44.1
Sharpe
0.04
Luna's Score
31/100
Recommendation
Sell
Luna says (VANI | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
27.3%1 month
44.1%3 months
60.3%6 months
73.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.02
Debt to equity
0.84
Debt to assets
0.42
Ent. to EBITDA
-3.93
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-24.90M
MarketCap
64.65M
MarketCap(USD)
64.65M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-86.10
Short ratio
8.90
Short perc.
2.98
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.16
Range1M
0.19
Range3M
0.42
Volumes: Market Activity
Rel. volume
0.54
Price X volume
136.63K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.93 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.02 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 60.29 | 72.80 | Par |
| Debt to Equity | 0.84 | -1.23 | Expensive |
| Debt to Assets | 0.42 | 0.25 | Expensive |
| Market Cap | 64.65M | 3.66B | Emerging |
